Colgate-Palmolive CL
NYSE · Perfumes, Cosmetics & Other Toilet Preparations · $78.8BData provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via DatabentoOperating leverage — margins
| Line Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY Δ | 4Y CAGR | Trend |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $17.4B | $18.0B | $19.5B | $20.1B | $20.4B | +1.4% | +4.0% | |
| Cost of Revenue (COGS) | $7.0B | $7.7B | $8.1B | $7.9B | $8.1B | +2.4% | +3.6% | |
| Gross Profit | $10.4B | $10.2B | $11.3B | $12.2B | $12.3B | +0.7% | +4.2% | |
| Research & Development (R&D) | $307.0M | $320.0M | $343.0M | $355.0M | $366.0M | +3.1% | +4.5% | |
| Selling, General & Admin (SG&A) | $6.4B | $6.6B | $7.2B | $7.7B | $7.9B | +2.3% | +5.4% | |
| Total Operating Expenses | $7.0B | $7.4B | $7.3B | $7.9B | $8.9B | +13.3% | +6.2% | |
| Operating Income (EBIT) | $3.3B | $2.9B | $4.0B | $4.3B | $3.3B | −22.5% | −0.2% | |
| Interest Expense | — | $167.0M | $287.0M | $292.0M | $267.0M | −8.6% | +16.9% | |
| Income Tax Expense | $749.0M | $693.0M | $937.0M | $907.0M | $798.0M | −12.0% | +1.6% | |
| GAAP Net Income | $2.2B | $1.8B | $2.3B | $2.9B | $2.1B | −26.2% | −0.4% | |
| Diluted EPS | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 | −25.1% | +0.8% | |
| Diluted Shares | 848.3M | 838.8M | 829.2M | 823.2M | 811.1M | −1.5% | −1.1% | |
| Balance Sheet | ||||||||
| Cash & Equivalents | $832.0M | $775.0M | $966.0M | $1.1B | $1.3B | +17.5% | +11.5% | |
| Inventory | $1.7B | $2.1B | $1.9B | $2.0B | $2.0B | +2.3% | +4.7% | |
| Total Current Assets | $4.4B | $5.1B | $5.3B | $5.3B | $5.7B | +7.4% | +6.7% | |
| Total Assets | $15.0B | $15.7B | $16.4B | $16.0B | $16.3B | +1.8% | +2.1% | |
| Total Current Liabilities | $4.1B | $4.0B | $4.7B | $5.8B | $6.9B | +19.0% | +14.0% | |
| Total Debt (Short + Long Term) | $7.2B | $8.8B | $8.2B | $7.7B | $9.0B | +16.9% | +5.6% | |
| Total Liabilities | $14.1B | $14.9B | $15.4B | $15.5B | $16.0B | +3.0% | +3.2% | |
| Stockholders' Equity | $971.0M | $806.0M | $957.0M | $544.0M | $365.0M | −32.9% | −21.7% | |
| Net Cash / (Net Debt) | $-6.4B | $-8.0B | $-7.3B | $-6.6B | $-7.7B | −16.8% | — | |
| Invested Capital | $7.3B | $8.8B | $8.2B | $7.1B | $8.0B | +13.0% | +2.3% | |
| Cash Flow & Capital Allocation | ||||||||
| Operating Cash Flow (OCF) | $3.3B | $2.6B | $3.7B | $4.1B | $4.2B | +2.2% | +6.0% | |
| Depreciation & Amortization (D&A) | $556.0M | $545.0M | $567.0M | $605.0M | $630.0M | +4.1% | +3.2% | |
| Stock-Based Compensation (SBC) | $135.0M | $125.0M | $122.0M | $135.0M | $155.0M | +14.8% | +3.5% | |
| Capital Expenditures (CapEx) | $567.0M | $696.0M | — | — | $696.0M | — | +5.3% | |
| Free Cash Flow (FCF) | $2.8B | $1.9B | — | — | $3.5B | — | +6.2% | |
| True FCF (ex-SBC Owner Cash) | $2.6B | $1.7B | — | — | $3.3B | — | +6.3% | |
| Share Repurchases (Buybacks) | $1.3B | $1.3B | $1.1B | $1.7B | $1.2B | −30.4% | −2.2% | |
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.